ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Microbiome Analysis Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-35C17151
Home | Market Reports | Science| Biological Sciences
Global Human Microbiome Analysis Market Research Report 2024
BUY CHAPTERS

Global Human Microbiome Analysis Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-35C17151
Report
November 2025
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Illumina Inc
IGATech
BaseClear
Viome, Inc.
Ixcela, Inc
ProDigest
Enterome
Zoe
Qiagen NV
Genetic Analysis
Microba Life Sciences
Goodgut
Origin Sciences
The BioCollective

Human Microbiome Analysis Market

The global Human Microbiome Analysis market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Human microbiome analysis refers to the process of studying the collection of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit the human body. These microorganisms reside in various body sites such as the gut, skin, mouth, respiratory tract, and reproductive organs, forming complex microbial communities known as the microbiome. The human microbiome plays a crucial role in maintaining health and influencing various physiological processes, including digestion, metabolism, immune function, and protection against pathogens. Imbalances or disruptions in the microbiome composition, known as dysbiosis, have been associated with a wide range of health conditions, including gastrointestinal disorders, metabolic disorders, autoimmune diseases, and mental health disorders.
Human microbiome analysis can provide valuable insights into the composition, diversity, and function of microbial communities within the body. It has applications in research, clinical diagnostics, personalized medicine, and the development of microbiome-targeted therapies and interventions aimed at promoting health and treating diseases. Additionally, microbiome analysis may help identify biomarkers of disease risk, monitor treatment responses, and guide interventions to modulate the microbiome for therapeutic purposes.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Human Microbiome Analysis leading manufacturers including Illumina, IGATech, Genetic Analysis, BaseClear, Microba Life Sciences, Viome, Goodgut, Origin Sciences, Ixcela, ProDigest, etc., dominate supply; the top five capture approximately % of global revenue, with Illumina leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Human Microbiome Analysis market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Human Microbiome Analysis Market Report

Report Metric Details
Report Name Human Microbiome Analysis Market
Segment by Type
  • 16S rRNA Sequencing
  • Shot Gun Metagenomics
  • Metatranscriptomics
  • Others
Segment by Application
  • Hospitals
  • Research Institutes
  • Pharmaceutical Companies
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, IGATech, Genetic Analysis, BaseClear, Microba Life Sciences, Viome, Goodgut, Origin Sciences, Ixcela, ProDigest, Enterome, The BioCollective, ZOE, Qiagen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Human Microbiome Analysis study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Human Microbiome Analysis Market report?

Ans: The main players in the Human Microbiome Analysis Market are Illumina, IGATech, Genetic Analysis, BaseClear, Microba Life Sciences, Viome, Goodgut, Origin Sciences, Ixcela, ProDigest, Enterome, The BioCollective, ZOE, Qiagen

What are the Application segmentation covered in the Human Microbiome Analysis Market report?

Ans: The Applications covered in the Human Microbiome Analysis Market report are Hospitals, Research Institutes, Pharmaceutical Companies

What are the Type segmentation covered in the Human Microbiome Analysis Market report?

Ans: The Types covered in the Human Microbiome Analysis Market report are 16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics, Others

1 Study Coverage
1.1 Introduction to Human Microbiome Analysis: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Human Microbiome Analysis Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 16S rRNA Sequencing
1.2.3 Shot Gun Metagenomics
1.2.4 Metatranscriptomics
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Human Microbiome Analysis Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Research Institutes
1.3.4 Pharmaceutical Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Microbiome Analysis Revenue Estimates and Forecasts 2020-2031
2.2 Global Human Microbiome Analysis Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Human Microbiome Analysis Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Human Microbiome Analysis Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 16S rRNA Sequencing Market Size by Players
3.3.2 Shot Gun Metagenomics Market Size by Players
3.3.3 Metatranscriptomics Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Human Microbiome Analysis Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Human Microbiome Analysis Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Human Microbiome Analysis Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Human Microbiome Analysis Market Size by Type (2020-2031)
6.4 North America Human Microbiome Analysis Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Human Microbiome Analysis Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Human Microbiome Analysis Market Size by Type (2020-2031)
7.4 Europe Human Microbiome Analysis Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Human Microbiome Analysis Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Human Microbiome Analysis Market Size by Type (2020-2031)
8.4 Asia-Pacific Human Microbiome Analysis Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Human Microbiome Analysis Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Human Microbiome Analysis Market Size by Type (2020-2031)
9.4 Central and South America Human Microbiome Analysis Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Human Microbiome Analysis Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Human Microbiome Analysis Market Size by Type (2020-2031)
10.4 Middle East and Africa Human Microbiome Analysis Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Human Microbiome Analysis Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Illumina
11.1.1 Illumina Corporation Information
11.1.2 Illumina Business Overview
11.1.3 Illumina Human Microbiome Analysis Product Features and Attributes
11.1.4 Illumina Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.1.5 Illumina Human Microbiome Analysis Revenue by Product in 2024
11.1.6 Illumina Human Microbiome Analysis Revenue by Application in 2024
11.1.7 Illumina Human Microbiome Analysis Revenue by Geographic Area in 2024
11.1.8 Illumina Human Microbiome Analysis SWOT Analysis
11.1.9 Illumina Recent Developments
11.2 IGATech
11.2.1 IGATech Corporation Information
11.2.2 IGATech Business Overview
11.2.3 IGATech Human Microbiome Analysis Product Features and Attributes
11.2.4 IGATech Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.2.5 IGATech Human Microbiome Analysis Revenue by Product in 2024
11.2.6 IGATech Human Microbiome Analysis Revenue by Application in 2024
11.2.7 IGATech Human Microbiome Analysis Revenue by Geographic Area in 2024
11.2.8 IGATech Human Microbiome Analysis SWOT Analysis
11.2.9 IGATech Recent Developments
11.3 Genetic Analysis
11.3.1 Genetic Analysis Corporation Information
11.3.2 Genetic Analysis Business Overview
11.3.3 Genetic Analysis Human Microbiome Analysis Product Features and Attributes
11.3.4 Genetic Analysis Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.3.5 Genetic Analysis Human Microbiome Analysis Revenue by Product in 2024
11.3.6 Genetic Analysis Human Microbiome Analysis Revenue by Application in 2024
11.3.7 Genetic Analysis Human Microbiome Analysis Revenue by Geographic Area in 2024
11.3.8 Genetic Analysis Human Microbiome Analysis SWOT Analysis
11.3.9 Genetic Analysis Recent Developments
11.4 BaseClear
11.4.1 BaseClear Corporation Information
11.4.2 BaseClear Business Overview
11.4.3 BaseClear Human Microbiome Analysis Product Features and Attributes
11.4.4 BaseClear Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.4.5 BaseClear Human Microbiome Analysis Revenue by Product in 2024
11.4.6 BaseClear Human Microbiome Analysis Revenue by Application in 2024
11.4.7 BaseClear Human Microbiome Analysis Revenue by Geographic Area in 2024
11.4.8 BaseClear Human Microbiome Analysis SWOT Analysis
11.4.9 BaseClear Recent Developments
11.5 Microba Life Sciences
11.5.1 Microba Life Sciences Corporation Information
11.5.2 Microba Life Sciences Business Overview
11.5.3 Microba Life Sciences Human Microbiome Analysis Product Features and Attributes
11.5.4 Microba Life Sciences Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.5.5 Microba Life Sciences Human Microbiome Analysis Revenue by Product in 2024
11.5.6 Microba Life Sciences Human Microbiome Analysis Revenue by Application in 2024
11.5.7 Microba Life Sciences Human Microbiome Analysis Revenue by Geographic Area in 2024
11.5.8 Microba Life Sciences Human Microbiome Analysis SWOT Analysis
11.5.9 Microba Life Sciences Recent Developments
11.6 Viome
11.6.1 Viome Corporation Information
11.6.2 Viome Business Overview
11.6.3 Viome Human Microbiome Analysis Product Features and Attributes
11.6.4 Viome Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.6.5 Viome Recent Developments
11.7 Goodgut
11.7.1 Goodgut Corporation Information
11.7.2 Goodgut Business Overview
11.7.3 Goodgut Human Microbiome Analysis Product Features and Attributes
11.7.4 Goodgut Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.7.5 Goodgut Recent Developments
11.8 Origin Sciences
11.8.1 Origin Sciences Corporation Information
11.8.2 Origin Sciences Business Overview
11.8.3 Origin Sciences Human Microbiome Analysis Product Features and Attributes
11.8.4 Origin Sciences Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.8.5 Origin Sciences Recent Developments
11.9 Ixcela
11.9.1 Ixcela Corporation Information
11.9.2 Ixcela Business Overview
11.9.3 Ixcela Human Microbiome Analysis Product Features and Attributes
11.9.4 Ixcela Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.9.5 Ixcela Recent Developments
11.10 ProDigest
11.10.1 ProDigest Corporation Information
11.10.2 ProDigest Business Overview
11.10.3 ProDigest Human Microbiome Analysis Product Features and Attributes
11.10.4 ProDigest Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Enterome
11.11.1 Enterome Corporation Information
11.11.2 Enterome Business Overview
11.11.3 Enterome Human Microbiome Analysis Product Features and Attributes
11.11.4 Enterome Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.11.5 Enterome Recent Developments
11.12 The BioCollective
11.12.1 The BioCollective Corporation Information
11.12.2 The BioCollective Business Overview
11.12.3 The BioCollective Human Microbiome Analysis Product Features and Attributes
11.12.4 The BioCollective Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.12.5 The BioCollective Recent Developments
11.13 ZOE
11.13.1 ZOE Corporation Information
11.13.2 ZOE Business Overview
11.13.3 ZOE Human Microbiome Analysis Product Features and Attributes
11.13.4 ZOE Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.13.5 ZOE Recent Developments
11.14 Qiagen
11.14.1 Qiagen Corporation Information
11.14.2 Qiagen Business Overview
11.14.3 Qiagen Human Microbiome Analysis Product Features and Attributes
11.14.4 Qiagen Human Microbiome Analysis Revenue and Gross Margin (2020-2025)
11.14.5 Qiagen Recent Developments
12 Human Microbiome AnalysisIndustry Chain Analysis
12.1 Human Microbiome Analysis Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Human Microbiome Analysis Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Human Microbiome Analysis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Illumina Inc
IGATech
BaseClear
Viome, Inc.
Ixcela, Inc
ProDigest
Enterome
Zoe
Qiagen NV
Genetic Analysis
Microba Life Sciences
Goodgut
Origin Sciences
The BioCollective
List of Tables
 Table 1. Global Human Microbiome Analysis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Human Microbiome Analysis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Human Microbiome Analysis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Human Microbiome Analysis Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Human Microbiome Analysis Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Human Microbiome Analysis Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Human Microbiome Analysis Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Human Microbiome Analysis by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Analysis as of 2024)
 Table 11. Global Human Microbiome Analysis Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Human Microbiome Analysis Companies Headquarters
 Table 13. Global Human Microbiome Analysis Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Human Microbiome Analysis Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Human Microbiome Analysis Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Human Microbiome Analysis Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Human Microbiome Analysis Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Human Microbiome Analysis High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Human Microbiome Analysis Growth Accelerators and Market Barriers
 Table 25. North America Human Microbiome Analysis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Human Microbiome Analysis Growth Accelerators and Market Barriers
 Table 27. Europe Human Microbiome Analysis Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Human Microbiome Analysis Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Human Microbiome Analysis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Human Microbiome Analysis Investment Opportunities and Key Challenges
 Table 31. Central and South America Human Microbiome Analysis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Human Microbiome Analysis Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Human Microbiome Analysis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Illumina Corporation Information
 Table 35. Illumina Description and Major Businesses
 Table 36. Illumina Product Features and Attributes
 Table 37. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Illumina Revenue Proportion by Product in 2024
 Table 39. Illumina Revenue Proportion by Application in 2024
 Table 40. Illumina Revenue Proportion by Geographic Area in 2024
 Table 41. Illumina Human Microbiome Analysis SWOT Analysis
 Table 42. Illumina Recent Developments
 Table 43. IGATech Corporation Information
 Table 44. IGATech Description and Major Businesses
 Table 45. IGATech Product Features and Attributes
 Table 46. IGATech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. IGATech Revenue Proportion by Product in 2024
 Table 48. IGATech Revenue Proportion by Application in 2024
 Table 49. IGATech Revenue Proportion by Geographic Area in 2024
 Table 50. IGATech Human Microbiome Analysis SWOT Analysis
 Table 51. IGATech Recent Developments
 Table 52. Genetic Analysis Corporation Information
 Table 53. Genetic Analysis Description and Major Businesses
 Table 54. Genetic Analysis Product Features and Attributes
 Table 55. Genetic Analysis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Genetic Analysis Revenue Proportion by Product in 2024
 Table 57. Genetic Analysis Revenue Proportion by Application in 2024
 Table 58. Genetic Analysis Revenue Proportion by Geographic Area in 2024
 Table 59. Genetic Analysis Human Microbiome Analysis SWOT Analysis
 Table 60. Genetic Analysis Recent Developments
 Table 61. BaseClear Corporation Information
 Table 62. BaseClear Description and Major Businesses
 Table 63. BaseClear Product Features and Attributes
 Table 64. BaseClear Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. BaseClear Revenue Proportion by Product in 2024
 Table 66. BaseClear Revenue Proportion by Application in 2024
 Table 67. BaseClear Revenue Proportion by Geographic Area in 2024
 Table 68. BaseClear Human Microbiome Analysis SWOT Analysis
 Table 69. BaseClear Recent Developments
 Table 70. Microba Life Sciences Corporation Information
 Table 71. Microba Life Sciences Description and Major Businesses
 Table 72. Microba Life Sciences Product Features and Attributes
 Table 73. Microba Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Microba Life Sciences Revenue Proportion by Product in 2024
 Table 75. Microba Life Sciences Revenue Proportion by Application in 2024
 Table 76. Microba Life Sciences Revenue Proportion by Geographic Area in 2024
 Table 77. Microba Life Sciences Human Microbiome Analysis SWOT Analysis
 Table 78. Microba Life Sciences Recent Developments
 Table 79. Viome Corporation Information
 Table 80. Viome Description and Major Businesses
 Table 81. Viome Product Features and Attributes
 Table 82. Viome Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Viome Recent Developments
 Table 84. Goodgut Corporation Information
 Table 85. Goodgut Description and Major Businesses
 Table 86. Goodgut Product Features and Attributes
 Table 87. Goodgut Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Goodgut Recent Developments
 Table 89. Origin Sciences Corporation Information
 Table 90. Origin Sciences Description and Major Businesses
 Table 91. Origin Sciences Product Features and Attributes
 Table 92. Origin Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Origin Sciences Recent Developments
 Table 94. Ixcela Corporation Information
 Table 95. Ixcela Description and Major Businesses
 Table 96. Ixcela Product Features and Attributes
 Table 97. Ixcela Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Ixcela Recent Developments
 Table 99. ProDigest Corporation Information
 Table 100. ProDigest Description and Major Businesses
 Table 101. ProDigest Product Features and Attributes
 Table 102. ProDigest Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. ProDigest Recent Developments
 Table 104. Enterome Corporation Information
 Table 105. Enterome Description and Major Businesses
 Table 106. Enterome Product Features and Attributes
 Table 107. Enterome Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Enterome Recent Developments
 Table 109. The BioCollective Corporation Information
 Table 110. The BioCollective Description and Major Businesses
 Table 111. The BioCollective Product Features and Attributes
 Table 112. The BioCollective Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. The BioCollective Recent Developments
 Table 114. ZOE Corporation Information
 Table 115. ZOE Description and Major Businesses
 Table 116. ZOE Product Features and Attributes
 Table 117. ZOE Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. ZOE Recent Developments
 Table 119. Qiagen Corporation Information
 Table 120. Qiagen Description and Major Businesses
 Table 121. Qiagen Product Features and Attributes
 Table 122. Qiagen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Qiagen Recent Developments
 Table 124. Raw Materials Key Suppliers
 Table 125. Distributors List
 Table 126. Market Trends and Market Evolution
 Table 127. Market Drivers and Opportunities
 Table 128. Market Challenges, Risks, and Restraints
 Table 129. Research Programs/Design for This Report
 Table 130. Key Data Information from Secondary Sources
 Table 131. Key Data Information from Primary Sources


List of Figures
 Figure 1. Human Microbiome Analysis Product Picture
 Figure 2. Global Human Microbiome Analysis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 16S rRNA Sequencing Product Picture
 Figure 4. Shot Gun Metagenomics Product Picture
 Figure 5. Metatranscriptomics Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Human Microbiome Analysis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Hospitals
 Figure 9. Research Institutes
 Figure 10. Pharmaceutical Companies
 Figure 11. Human Microbiome Analysis Report Years Considered
 Figure 12. Global Human Microbiome Analysis Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Human Microbiome Analysis Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Human Microbiome Analysis Revenue Market Share by Region (2020-2031)
 Figure 16. Global Human Microbiome Analysis Revenue Market Share Ranking (2024)
 Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 18. 16S rRNA Sequencing Revenue Market Share by Player in 2024
 Figure 19. Shot Gun Metagenomics Revenue Market Share by Player in 2024
 Figure 20. Metatranscriptomics Revenue Market Share by Player in 2024
 Figure 21. Others Revenue Market Share by Player in 2024
 Figure 22. Global Human Microbiome Analysis Revenue Market Share by Type (2020-2031)
 Figure 23. Global Human Microbiome Analysis Revenue Market Share by Application (2020-2031)
 Figure 24. North America Human Microbiome Analysis Revenue YoY (2020-2031) & (US$ Million)
 Figure 25. North America Top 5 Players Human Microbiome Analysis Revenue (US$ Million) in 2024
 Figure 26. North America Human Microbiome Analysis Revenue (US$ Million) by Type (2020 - 2031)
 Figure 27. North America Human Microbiome Analysis Revenue (US$ Million) by Application (2020-2031)
 Figure 28. US Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 29. Canada Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 30. Mexico Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 31. Europe Human Microbiome Analysis Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. Europe Top 5 Players Human Microbiome Analysis Revenue (US$ Million) in 2024
 Figure 33. Europe Human Microbiome Analysis Revenue (US$ Million) by Type (2020-2031)
 Figure 34. Europe Human Microbiome Analysis Revenue (US$ Million) by Application (2020-2031)
 Figure 35. Germany Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 36. France Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 37. U.K. Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 38. Italy Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 39. Russia Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific Human Microbiome Analysis Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Asia-Pacific Top 8 Players Human Microbiome Analysis Revenue (US$ Million) in 2024
 Figure 42. Asia-Pacific Human Microbiome Analysis Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Asia-Pacific Human Microbiome Analysis Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Indonesia Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 45. Japan Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 46. South Korea Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 47. Australia Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 48. India Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 49. Indonesia Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 50. Vietnam Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 51. Malaysia Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 52. Philippines Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 53. Singapore Human Microbiome Analysis Revenue (2020-2031) & (US$ Million)
 Figure 54. Central and South America Human Microbiome Analysis Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Central and South America Top 5 Players Human Microbiome Analysis Revenue (US$ Million) in 2024
 Figure 56. Central and South America Human Microbiome Analysis Revenue (US$ Million) by Type (2020-2031)
 Figure 57. Central and South America Human Microbiome Analysis Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Brazil Human Microbiome Analysis Revenue (2020-2025) & (US$ Million)
 Figure 59. Argentina Human Microbiome Analysis Revenue (2020-2025) & (US$ Million)
 Figure 60. Middle East and Africa Human Microbiome Analysis Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Middle East and Africa Top 5 Players Human Microbiome Analysis Revenue (US$ Million) in 2024
 Figure 62. South America Human Microbiome Analysis Revenue (US$ Million) by Type (2020-2031)
 Figure 63. Middle East and Africa Human Microbiome Analysis Revenue (US$ Million) by Application (2020-2031)
 Figure 64. GCC Countries Human Microbiome Analysis Revenue (2020-2025) & (US$ Million)
 Figure 65. Israel Human Microbiome Analysis Revenue (2020-2025) & (US$ Million)
 Figure 66. Egypt Human Microbiome Analysis Revenue (2020-2025) & (US$ Million)
 Figure 67. South Africa Human Microbiome Analysis Revenue (2020-2025) & (US$ Million)
 Figure 68. Human Microbiome Analysis Industry Chain Mapping
 Figure 69. Channels of Distribution (Direct Vs Distribution)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Human Microbiome Sequencing Services Market Research Report 2024
Global Human Microbiome Modulators Market Insights Forecast to 2030
Global Direct to Consumer Microbiome Analyzing Market Insights Forecast to 2030
Global Gut Microbiome Testing Service Market Research Report 2024
Global Microbiome Cosmetic Market Research Report 2025
Microbiome Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gut Microbiome Market Research Report 2024
Global Microbial Regulators in Human Body Market Research Report 2024
Global Skin Microbiome Modulator Market Research Report 2025
Global Microbiome Drugs Market Research Report 2024
Global Microbiology Culture Market Insights Forecast to 2030
Microbiome Skincare Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbiome Sample Preparation Technology Market Research Report 2024
Global Microbial Analyzers Market Insights Forecast to 2030
Human Microbiome Therapeutic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Identification Market Research Report 2025
Global Microbiome Cosmetic Product Market Research Report 2025
Global Human Microbiome Sequencing Market Research Report 2024
Global Microbiome Therapies Market Research Report 2024
Global Agricultural Microbiome Analysis Service Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions